Delivery Order SPE2DB20D2104-SPE2DB25FNANS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count) with a contract value of $2,205.41. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract is valued at $1,510.57 with a firm fixed price structure and an ultimate completion date of August 19, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets (30-count packages) with a ceiling value of $4,107.11. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a ceiling value of $1,128.60. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The product will be performed and delivered...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 15, 2025, to supply Terbinafine HCL 250 mg tablets (30-count units) to the Defense Logistics Agency's Medical Supply Chain. This competitive, non-set-aside award carries a ceiling value of $19,915.11 under a firm fixed-price delivery order, with an ultimate completion date of September 16, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Terbinafine HCL 250 mg tablets (90-count supply) valued at $4,586.12. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Terbinafine HCL 250 mg tablets in 30-count packages, with a ceiling value of $1,013.59. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $1,628.05 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count packaging) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract utilizes firm fixed-price pricing and was awarded on a non-set-aside, competitive basis. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNANSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100s, with a ceiling value of $11,707.25. The delivery order represents a firm fixed price, competitive award with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company's extensive portfolio with the DLA includes generic and brand-name medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains. This terbinafine order represents a routine pharmaceutical delivery under the larger prime vendor contract structure, supporting the Defense Health Agency and other federal healthcare customers with essential medication supplies for military personnel and dependents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 9/16/25 |